A carregar...
Novel approaches for glioblastoma treatment: Focus on tumor heterogeneity, treatment resistance, and computational tools
BACKGROUND: Glioblastoma (GBM) is a highly aggressive primary brain tumor. Currently, the suggested line of action is the surgical resection followed by radiotherapy and treatment with the adjuvant temozolomide, a DNA alkylating agent. However, the ability of tumor cells to deeply infiltrate the sur...
Na minha lista:
| Publicado no: | Cancer Rep (Hoboken) |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7941428/ https://ncbi.nlm.nih.gov/pubmed/32729241 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cnr2.1220 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|